DBVT - DBV Technologies to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference | Benzinga
Châtillon, France, June 5, 2024
DBV Technologies to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company focused on treatment options for food allergies and other immunologic conditions with significant unmet medical need, today announced that Daniel Tassé, Chief Executive Officer, will participate in a fireside chat at the 45th Annual Goldman Sachs Global Healthcare Conference on Monday, June 10th, at 8:00 am EDT, as well as in one-on-one investor meetings.
A live webcast of the presentation can be accessed here, and will also be available on the Events section of Company's Investors website: https://dbv-technologies.com/investor-overview/events/
A replay will also be available on DBV Technologies' website for 90 days after ...